Telix Pharmaceuticals Annual Report 2018
Telix Pharmaceuticals Limited is pleased to provide its Annual Report 2018.
Telix Pharmaceuticals launches information site on illumet™ prostate cancer imaging product
Telix has just launched an information site on our illumet™ prostate cancer imaging product. The website provides an informative depository about how the product works and its potential in clinical use for prostate cancer.
Strategy Update – Acceleration of Prostate Cancer Therapy Program
Telix Pharmaceuticals Limited today announced a strategy update for the TLX591 (prostate therapy) program.
Telix Pharmaceuticals Ltd Detailed Program Update January 2019
Telix Pharmaceuticals Limited is pleased to provide a detailed Program Update January 2019.
Telix Pharmaceuticals & Radboud University Medical Centre Conclude Clinical Collaboration Agreement
Telix Pharmaceuticals has today announced a clinical collaboration with Radboud University Medical Center.
BioSpectrum Asia Interview with Dr Nishimura on APAC Oncology Market
Telix is pleased to provide details of BioSpectrum Asia interview with Telix Japan President & COO Dr Shintaro Nishimura on the APAC oncology market & opportunities/challenges in the Japanese market for radiopharmaceutical products.
Odile Jaume to Lead Telix’s European Operations
Telix Pharmaceuticals Limited is delighted to announce the appointment of Ms. Odile Jaume as President and Chief Operating Officer (COO) of Telix’s European operations.
Telix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key Executives
Telix Pharmaceuticals Limited is pleased to announce the establishment Telix Pharmaceuticals (Japan) Ltd and appointment of the first two members of the Japanese leadership team.
Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration
Telix has today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK)
Telix Pharmaceuticals Appointed Dr. Bernard Lambert as President of Telix Pharmaceuticals (US) Inc.
Telix has today announced the appointment of Dr. Bernard Lambert as President and Chief Operating Officer (COO) of Telix’s US subsidiary.